10 results
8-K
EX-10.1
FENC
Fennec Pharmaceuticals Inc
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
Technology Transfer.
Licensee may, at any time during the Initial Term or any Subsequent Term, procure an additional or replacement supplier of Product
8-K
EX-1.1
FENC
Fennec Pharmaceuticals Inc
4 May 20
Fennec Announces Proposed Public Offering of Common Shares
12:00am
with the intent to influence unlawfully (A) a customer or supplier of the Company or any Subsidiary to alter the customer’s or supplier’s level or type
20-F
sqf4qzz168fzvc
31 Mar 05
Annual report (foreign)
12:00am
20FR12B/A
1tx6yjkjjr38i ynaq
5 Nov 04
Initial registration of securities (foreign private issuers) (amended)
12:00am
20FR12B/A
v02saco44
8 Oct 04
Initial registration of securities (foreign private issuers) (amended)
12:00am
20FR12B
EX-4.6
t8myx7rqzfb5s87qdln
17 Sep 04
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
1apafdi4
17 Sep 04
Initial registration of securities (foreign private issuers)
12:00am
- Prev
- 1
- Next